Clinical Trial Update: Evaluation of the Impact of Medium-chain Fatty Acids in the Evolution of Newly Diagnosed Mild Cognitive Impairment [NA]

View source ↗

Summary

A clinical trial evaluating the impact of medium-chain fatty acids on the evolution of newly diagnosed Mild Cognitive Impairment is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Snippet

Sponsor: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | Conditions: Mild Cognitive Impairment (MCI) | NA | Status: RECRUITING